Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CGS 8515

Known as: CGS-8515 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Objective: The 5-lipoxygenase products, especially sulfidopeptide leukotrienes take an important role in the pathogenesis of… Expand
Is this relevant?
1995
1995
Effects of platelet-activating receptor antagonists WEB 2086 (1.0-30.0 mg.kg-1 intravenously) and BN 50730 (10.0 mg.kg-1… Expand
Is this relevant?
1993
1993
We evaluated the effect of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 alpha (IL-1 alpha) on pig cardiopulmonary… Expand
Is this relevant?
1992
1992
In the present study it was found that lipoxygenase inhibitors prevent LPS-, but not tumor necrosis factor alpha (TNF alpha… Expand
Is this relevant?
1990
1990
The o-naphthoquinone derivative, CGS 8515 (I), is a potent inhibitor (IC50, 0.1 µM) of 5-lipoxygenase, but its therapeutic… Expand
Is this relevant?
1989
1989
1. CGS 8515 selectively inhibited 5-LO (IC50 = 0.1 microM) with negligible effect on CO, 12-LO, 15-LO and TxS at concentrations… Expand
Is this relevant?
1988
1988
CGS 8515 inhibited 5-hydroxyeicosatetraenoic acid (5-HETE) and leukotriene B4 synthesis in guinea pig leukocytes (IC50 = 0.1… Expand
Is this relevant?
1988
1988
1. Ovalbumen (100 micrograms)-induced coronary vasoconstriction and decrease in cardiac developed tension were studied in… Expand
Is this relevant?
1988
1988
To determine the relative importance of arachidonic acid pathway products on vulnerability to ventricular fibrillation (VF), we… Expand
Is this relevant?